Maze Therapeutics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $62.55. The average 1-year stock price forecast is 109.34% higher than the current stock price, while the lowest is $46 (+53.95%) and the highest is $110 (+268.14%).

Price Target: $62.55 (+109.34%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$46	$62.55	$55	$110
Change	+53.95%	+109.34%	+84.07%	+268.14%

Analyst Ratings

The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	11	11	11	11
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salim Syed Mizuho Securities	Mizuho Securities	Buy Maintains $97	Buy	Maintains	$97	+224.63%	Jun 23, 2026
Ananda Ghosh H.C. Wainwright	H.C. Wainwright	Buy Reiterates $110	Buy	Reiterates	$110	+268.14%	Jun 22, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $58 → $53	Buy	Maintains	$58 → $53	+77.38%	May 23, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $57	Buy	Maintains	$57	+90.76%	May 16, 2026
Danielle Brill Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

20.00M

Revenue Next Year

8.85M

from 20.00M

-55.77%

from 20.00M

EPS This Year

-2.67

from -3.05

EPS Next Year

-3.19

from -2.67

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	167.50M	-	20.00M
Gross Profit	-	-	167.50M	-	20.00M
Gross Margin	-	-	100.00%	-	100.00%
Operating Income	-111.03M	-98.55M	57.59M	-142.90M	-166.92M
Net Income	-114.94M	-100.42M	52.23M	-131.12M	-157.95M
EPS	-	-	-	-3.05	-2.67
Free Cash Flow	-	-52.55M	52.09M	-72.52M	-153.99M
No. Analysts	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	40.0M
Avg	20.0M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	200.0%
Avg	-55.8%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-2.00
Avg	-2.67
Low	-3.07

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-